hyperphosphatemia

SHANGHAI, China – May 6, 2026 Alebund Pharmaceuticals (Jiangsu) Limited has announced the completion of patient enrollment in its...

Redwood City, CA – March 17, 2026 – R1 Therapeutics has officially emerged from stealth mode, announcing an oversubscribed...

Los Altos, California, October 28, 2025 — Unicycive Therapeutics, Inc., a clinical-stage biopharmaceutical company developing treatments for kidney disease,...